Genetic Biomarkers to Identify the Risk of Osteonecrosis in Children with Acute Lymphoblastic Leukemia.

about

Genetic Biomarkers to Identify the Risk of Osteonecrosis in Children with Acute Lymphoblastic Leukemia.

Item

http://www.wikidata.org/entity/Q51671049

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Genetic Biomarkers to Identify ...... Acute Lymphoblastic Leukemia.

@en

Genetic Biomarkers to Identify ...... Acute Lymphoblastic Leukemia.

@nl

type

Item

label

Genetic Biomarkers to Identify ...... Acute Lymphoblastic Leukemia.

@en

Genetic Biomarkers to Identify ...... Acute Lymphoblastic Leukemia.

@nl

prefLabel

Genetic Biomarkers to Identify ...... Acute Lymphoblastic Leukemia.

@en

Genetic Biomarkers to Identify ...... Acute Lymphoblastic Leukemia.

@nl

P1476

Genetic Biomarkers to Identify ...... Acute Lymphoblastic Leukemia.

@en

P2093

André G Uitterlinden

http://www.w3.org/2001/XMLSchema#string

Marissa A H den Hoed

http://www.w3.org/2001/XMLSchema#string

Saskia M F Pluijm

http://www.w3.org/2001/XMLSchema#string

P2860

A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group

Genome-wide association studies using single-nucleotide polymorphisms versus haplotypes: an empirical comparison with data from the North American Rheumatoid Arthritis Consortium.

Bone morbidity in childhood leukemia: epidemiology, mechanisms, diagnosis, and treatment

Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.

Asparaginase Potentiates Glucocorticoid-Induced Osteonecrosis in a Mouse Model

Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia

Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial

Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia

Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia.

Practical issues in building risk-predicting models for complex diseases

P2888

s40291-016-0226-z

P304

519-522

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40291-016-0226-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

André Uitterlinden

Rob Pieters

Marry M van den Heuvel-Eibrink

P577

2016-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27365083

http://www.w3.org/2001/XMLSchema#string

P921

leukemia